What is Genentech access solutions?
Genentech Access Solutions is committed to helping patients access the Genentech medicines they need In 2020, Genentech Access Solutions helped more than 266,000 eligible patients with access issues.
How do I pay for my Genentech medicine?
If you are concerned about paying for your Genentech medicine, please call our Patient Resource Center at (877) 436-3683. Ready to Enroll? Fill out the Patient Consent Form and send it to Genentech Access Solutions to get started. The form can be submitted in any of these 3 ways: We are here to help.
What is the Genentech patient Foundation?
The Genentech Patient Foundation gives free Genentech medicine to people who don’t have insurance coverage or who have financial concerns. See if You Qualify Find out if the Genentech Patient Foundation can help you.
Can I get Genentech medicine without insurance?
Living with a serious illness can come with many challenges. Getting Genentech medicines shouldn’t be one of them. The Genentech Patient Foundation gives free Genentech medicine to people who don’t have insurance coverage or who have financial concerns. See if You Qualify Find out if the Genentech Patient Foundation can help you.
See more
What is the Genentech Patient Foundation?
The Genentech Patient Foundation gives free Genentech medicine to people who don't have insurance coverage or who have financial concerns.
What drugs does Genentech make?
Our Medicines & ProductsMedicines.Actemra® (TOCILIZUMAB [authorized for Emergency Use])Actemra® (tocilizumab)Activase® (alteplase)Alecensa® (alectinib)Avastin® (bevacizumab)Boniva Tablets® (ibandronate sodium)Cathflo Activase® (alteplase)More items...
What is Genentech best known for?
Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
Who is Genentech owned by?
As of July 2021, Genentech employed 13,539 people....Genentech.TypePrivate ( Independent subsidiary)Number of employees13,539 (July 2021)ParentHoffmann-La RocheWebsitewww.gene.com7 more rows
How many drugs does Genentech have?
Genentech, Inc. manufactures, markets and/or distributes more than 47 drugs in the United States.
Which one of these is an approved drug by the firm Genentech?
The Genentech medicines supported by the Genentech Patient Foundation are: Actemra® (tocilizumab) Activase® (alteplase) Alecensa® (alectinib)
What drugs does Roche make?
All. Actemra/RoActemra. Alecensa. ... Anaemia. Mircera. NeoRecormon.Cancer (blood tumours) Gazyva/Gazyvaro. MabThera / Rituxan. ... Cancer (blood cancers) Alecensa. Avastin. ... Dermatology. Roaccutane/Accutane.Haemophilia. Hemlibra.Infectious Diseases. Actemra/RoActemra. Copegus. ... Inflammatory & Autoimmune Diseases. Actemra/RoActemra. CellCept.More items...
What MS drugs does Genentech make?
About OCREVUS OCREVUS is approved by the FDA to treat relapsing or primary progressive forms of multiple sclerosis (MS).
What is the Genentech Foundation?from gene.com
The Genentech Foundation supports the American Chemical Society’s Bridge Project, a comprehensive program designed to increase the number of underrepresented students receiving doctoral degrees in the chemical sciences.
What is the number to call Genentech?from genentech-access.com
Getting your prescribed medicines should not be one of them. If you are concerned about paying for your Genentech medicine, please call our Patient Resource Center at (877) 436-3683.
How many students does Genentech support?from gene.com
Building off a decade-long partnership, the Genentech Foundation is now supporting approximately 100 underrepresented and low-income students per year from freshmen through Masters-level.
Does Genentech support evrysdi?from gene.com
Please Note: At this time, Genentech supports Evrysdi, Nutropin, Cellcept, Valcyte, and Fuzeon through a separate process.
Who gives Genentech medicine?from gene.com
The Genentech Patient Foundation gives free Genentech medicine to people who don’t have insurance coverage or who have financial concerns.
What is the number to call Genentech?from genentech-access.com
Getting your prescribed medicines should not be one of them. If you are concerned about paying for your Genentech medicine, please call our Patient Resource Center at (877) 436-3683.
Does Access Solutions offer a free consultation?from accesssolutionscalifornia.com
Access Solutions offers a FREE, no-obligation consultation service. If you are working with an architect, we will provide detailed product specifications and schematic drawings. Using our experience and knowledge of ADA and local building codes, we will help you select the best product for your needs.
Does Genentech support evrysdi?
Please Note: At this time, Genentech supports Evrysdi, Nutropin, Cellcept, Valcyte, and Fuzeon through a separate process.
Do you need to complete a patient consent form?
Both forms are required. No action can be taken until a completed Patient Consent Form and Prescriber Service Form have been received.
Eligibility
Genentech Access to Care Foundation (Pulmozyme), a patient assistance program provided by Genentech, Inc., offers Pulmozyme at no cost for one use to those who are eligible for the program. Eligibility is based off of the following requirements:
Other Tips
If you have any questions please call the Genentech, Inc. program directly.
Eligibility
Genentech Access to Care Foundation (Rituxan RA), a patient assistance program provided by Genentech, Inc., offers Rituxan at no cost for up to 90 days to those who are eligible for the program. Eligibility is based off of the following requirements:
Other Tips
If you have any questions please call the Genentech, Inc. program directly.
What is the number to call Genentech?from gene.com
Getting your prescribed medicines should not be one of them. If you are concerned about paying for your Genentech medicine, please call our Patient Resource Center at (877) 436-3683.
What are the most common adverse reactions and laboratory abnormalities reported in at least one indication by 20% of adult?from gene.com
Adult Patients: The most common adverse reactions and laboratory abnormalities reported in at least one indication by ≥20% of adult patients are diarrhea, pyrexia, nausea, tremor, neutropenia, anemia, graft rejection, thrombocytopenia, and vomiting.
What is the most important information I should know about VALCYTE?from gene.com
Blood and bone marrow problems. VALCYTE can affect the bone marrow lowering the amount of your white blood cells, red blood cells, and platelets and may cause serious and life-threatening problems.
How to take Valcyte?from gene.com
Take VALCYTE with food. Do not break or crush VALCYTE tablets. Avoid contact with your skin or eyes. If you come in contact with the contents of the tablet or oral solution, wash your skin well with soap and water or rinse your eyes well with plain water.
Is Valcyte a carcinogen?from gene.com
Mutagenicity and carcinogenicity: Based on animal studies, VALCYTE is potentially mutagenic and carcinogenic.
Is Valcyte generic?from drugs.com
A generic version of Valcyte is available, see valganciclovir prices.
Is Valctye safe for kidney transplant?from gene.com
It is not known if VALCTYE is safe and effective in children for prevention of CMV disease in liver transplant, in kidney transplant in infants less than 4 months of age, in heart transplant in infants less than 1 month of age, in children with AIDS who have CMV retinitis, and in infants with congenital CMV infection.
What is the phone number for a patient authorization?
Patient Authorization and Notice of Request for Transmission of Health Information Phone: (888) 754-7651Fax: (800) 305-1830
What is a message in Genentech?
message as a condition of any purchase of Genentech products or enrollment in Genentech Access Solutions or GATCF. Message and data rates may apply.
Is Genentech Transplant Access free?
Genentech Transplant Access Services is a free program for you from Genentech.